Clinical Trial Update: Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers [Phase 3]

View source ↗

Summary

The Phase 3 trial comparing prulifloxacin to placebo for acute bacterial gastroenteritis in adult travelers has completed. The study evaluates safety and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Gastroenteritis

Drugs mentioned

• Prulifloxacin (Prulifloxacin)

Snippet

Sponsor: Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Acute Bacterial Gastroenteritis | Phase 3 | Status: COMPLETED